Proteins and Peptides
21 October 2013
Phase 2 Clinical Data for Angiochem’s Lead Drug Candidate, ANG1005, in Breast Cancer Patients with Brain Metastases Revealed21 October 2013
Angiochem Initiates Phase 2 Clinical Study for Lead Drug Candidate, ANG1005, in Primary Brain Cancer17 October 2013
D-Pharm Commences Phase 2 Study with THR-18 In Stroke Patients Treated with Tissue Plasminogen Activator (tPA)16 October 2013
Novoeight® (turoctocog alfa) receives approval from the FDA16 October 2013
Hanmi Pharmaceutical Announces Multinational Phase IIb Clinical Studies on LAPS-Exendin4, New Biological Drug for Diabetes16 October 2013
Yale Researchers Initiate Clinical Trial Evaluating Halozyme’s Recombinant Hyaluronidase in Artificial Pancreas Study15 October 2013
European Commission approved reinstatement of aprotinin/Trasylol® marketing authorisation in European Union14 October 2013
MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA for the Treatment of Adults with Diabetes14 October 2013
Protalix BioTherapeutics Announces Positive Phase I Clinical Trial Results for Oral GCD in Gaucher Disease Patients10 October 2013
Karolinska Development AB (publ): Pergamum announces final data from Phase I/II study of LL-37 in patients with chronic leg ulcers9 October 2013
Catalyst Biosciences And Isu Abxis Announce Collaboration To Develop Next-Generation Best-In-Class Factor IX Therapeutics8 October 2013
Acorda Therapeutics Announces Initiation of Second Phase 1 GGF2 Clinical Trial in Heart Failure1 October 2013
New Data Analyses Show Significant Clinical and MRI Improvements with PLEGRIDY™ (Peginterferon Beta-1a)30 September 2013
Halozyme Presents PEGPH20 Phase 1b Clinical Trial Data at European Cancer Congress 201330 September 2013
DiaMedica Announces Successful Phase I/II Clinical Results in Type 2 Diabetic Patients28 September 2013
Ipsen : results from CLARINET® Phase III clinical trial showed the antiproliferative effect of Somatuline® in the treatment of non-functioning GEP-NETsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports